IMD Arrhythmia Detection Using Dynamic NID Thresholds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices (IMDs) often inaccurately detect ventricular arrhythmias caused by supraventricular tachycardia (SVT) as ventricular fibrillation or tachycardia, leading to inappropriate delivery of defibrillation or cardioversion shocks, which can cause patient discomfort and are ineffective in terminating SVT episodes.
Innovation Solution
IMDs employ a 'number of intervals to detect' (NID) threshold for ventricular arrhythmias, allowing for increased detection time and altering therapy delivery based on suspected non-lethal arrhythmia determinations, such as using anti-tachycardia pacing instead of shocks, and adjusting thresholds based on atrial and ventricular cycle length comparisons and other physiological parameters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If IMDs deliver defibrillation or cardioversion shocks upon detecting fast ventricular rhythms, then potentially lethal VF or VT can be terminated, but inappropriate therapy is delivered for non-lethal arrhythmias causing patient discomfort
Solution Approach 1:
The IMD performs preliminary analysis of atrial rhythm and applies SVT detection rules before delivering ventricular therapy. When an SVT is detected as the cause of fast ventricular rhythm, the IMD delays or avoids delivery of defibrillation/cardioversion shocks, thereby preventing inappropriate therapy while maintaining readiness to treat true VF/VT
Solution Approach 2:
The patent introduces an intermediary analysis layer that examines the relationship between atrial and ventricular rhythms. By analyzing whether fast ventricular rhythms are conducted from atrial arrhythmias (SVT), the system mediates between the need for aggressive ventricular therapy and the risk of inappropriate shock delivery
2Object-affected harmful factors
If IMDs apply SVT detection rules and analyze atrial rhythm to avoid false VF/VT detection, then inappropriate therapy delivery is reduced, but detection time and algorithm complexity increase
Solution Approach 1:
The detection algorithm is segmented into distinct functional modules: ventricular rhythm analysis, atrial rhythm analysis, SVT detection rules, and therapy decision logic. This modular segmentation makes the complex detection system more manageable and programmable while maintaining comprehensive arrhythmia discrimination capability
3Object-affected harmful factors
If clinicians program IMDs to prevent therapy delivery for slower ventricular rhythms, then inappropriate shock delivery is reduced, but slow arrhythmias that can accelerate into dangerous rhythms are not treated
Solution Approach 1:
The IMD employs dynamic NID thresholds that can be adjusted based on rhythm characteristics. For suspected non-lethal arrhythmias, the NID is increased to require more consecutive beats before therapy delivery, while maintaining lower thresholds for rhythms that meet established VF/VT criteria, thereby adapting the detection sensitivity to the specific arrhythmia type
Data Source
AI summary
An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).